Hedge Funds Make a Bundle on Edwards Lifesciences $EW Increase

Edwards Lifesciences Corp (EW) “third-quarter earnings rose 7.5% on a tax benefit as the heart-valve maker’s investments in its expected Sapien launch hurt margins, despite sales growth,” reports the Wall Street Journal. The news caused EW share prices to swell from $67.79 at close yesterday to $72 at close today.


The following hedge funds made a bundle on the increase:

1. Navellier & Associates – Louis Navellier: Gained $1.9 million

2. Sac Capital Advisors – Steven Cohen: Gained $1.6 million

3. Castlerock Asset Management – Paul Tanico: Gained $1.1 million

4. Driehaus Capital – Richard Driehaus: Gained $826,000

5. Aqr Capital Management – Cliff Asness: Gained $346,000

6. Sirios Capital Management – John Brennan: Gained $289,000

7. Renaissance Technologies – Jim Simons: Gained $287,000

8. Millennium Management – Israel Englander: Gained $223,000

9. Orbimed Advisors – Samuel Isaly: Gained $210,000

DISCLAIMER: These calculations assume that these hedge funds did not increase or reduce their stock positions in EW since the end of June. We did not take into account their option positions.

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!